Does DEFERASIROX Cause Neoplasm malignant? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Neoplasm malignant have been filed in association with DEFERASIROX (Deferasirox). This represents 0.4% of all adverse event reports for DEFERASIROX.
42
Reports of Neoplasm malignant with DEFERASIROX
0.4%
of all DEFERASIROX reports
10
Deaths
15
Hospitalizations
How Dangerous Is Neoplasm malignant From DEFERASIROX?
Of the 42 reports, 10 (23.8%) resulted in death, 15 (35.7%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which DEFERASIROX Alternatives Have Lower Neoplasm malignant Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX